Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.22.2.2
Stock Based Compensation (Details)
 9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Number of shares  
Number of shares, Beginning balance | shares 18,318,326
Number of shares, Grants | shares 1,200,000
Number of shares, Expirations | shares (400,000)
Number of shares, Exercises | shares (9,750)
Number of shares, Ending balance | shares 19,108,576
Options exercisable, Ending balance | shares 19,108,576
Weighted Average Exercise Price  
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.53
Weighted Average Exercise Price, Grants | $ / shares 0.21
Weighted Average Exercise Price, Expirations | $ / shares 1.03
Weighted Average Exercise Price, Exercises | $ / shares 0.25
Weighted Average Exercise Price, Ending balance | $ / shares 0.50
Options exercisable, Ending balance | $ / shares $ 0.50
Weighted Average Remaining Contractual Life (years)  
Weighted Average Remaining Contractual Life (years), Beginning balance 2 years 10 months 20 days
Weighted Average Remaining Contractual Life (years), Ending balance 2 years 6 months 14 days
Weighted Average Remaining Contractual Life exercisable, Ending balance 2 years 6 months 14 days
Aggregate Intrinsic Value  
Aggregate Intrinsic Value, Beginning balance | $ $ 2,961,965
Aggregate Intrinsic Value, Ending balance | $ 158,428
Options exercisable, Ending balance, Intrinsic value | $ $ 158,428